Vivos Therapeutics VVOS
NASDAQ VVOS
$0.13 0.00 (-2.08%)
As of: Oct 22, 2026 · 10:18 AM EDT

Vivos Therapeutics (VVOS) Long-Term Debt Issuances (2020 - 2026)

Updated

Vivos Therapeutics (VVOS) recorded Long-Term Debt Issuances of $1.63 million in Q2 2026, up 16.1% from the prior quarter.

Analysis

Vivos Therapeutics (VVOS) Long-Term Debt Issuances (2020 - 2026) Analysis & Trends

On a TTM basis, Vivos Therapeutics' Long-Term Debt Issuances came in at $4.06 million as of Jun 30, 2026; for FY2025, it came in at $10.67 million.

  • Annual Long-Term Debt Issuances has a five-year compound annual growth rate of 53.2% (FY2020 to FY2025).
  • Per Business Quant, the preceding three quarters came in at $1.4 million (Q1 2026), $1.45 million (Q4 2025) and -$417,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Thermo Fisher Scientific 253.62 Bn 232.65 Bn 4.88 Bn -
2 Abbott Laboratories 175.99 Bn 146.42 Bn 7.27 Bn -33.00 Mn
3 Danaher 164.43 Bn 148.23 Bn 3.61 Bn 6.56 Bn
4 Intuitive Surgical 154.62 Bn 134.04 Bn 1.96 Bn -
5 Medtronic 120.99 Bn 86.24 Bn 6.34 Bn -
6 Stryker 116.60 Bn 102.72 Bn 4.50 Bn -
7 Boston Scientific 66.31 Bn 61.08 Bn 3.85 Bn -
8 Becton Dickinson 54.00 Bn 51.14 Bn 2.32 Bn -
9 Edwards Lifesciences 51.33 Bn 35.34 Bn 1.35 Bn -
10 Vivos Therapeutics 2.31 Mn -6.73 Mn 2.95 Mn 1.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.63 Mn
Mar 31, 2026 1.40 Mn
Dec 31, 2025 1.45 Mn
Sep 30, 2025 -417,000.00
Dec 31, 2020 -67.00
API Access

Vivos Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=VVOS&period=max&api_key=YOUR_API_KEY